Share Name Share Symbol Market Type Share ISIN Share Description
Sareum Holdings LSE:SAR London Ordinary Share GB00B02RFS12 ORD 0.025P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.025p -3.13% 0.775p 0.75p 0.80p 0.80p 0.775p 0.80p 2,687,572.00 11:36:53
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -1.2 -0.0 - 20.50

Sareum (SAR) Latest News

More Sareum News
Sareum Takeover Rumours

Sareum (SAR) Share Charts

1 Year Sareum Chart

1 Year Sareum Chart

1 Month Sareum Chart

1 Month Sareum Chart

Intraday Sareum Chart

Intraday Sareum Chart

Sareum (SAR) Discussions and Chat

Sareum Forums and Chat

Date Time Title Posts
02/12/201620:42Sareum 2016432.00
30/11/201622:36Sareum 2015 1,671.00
27/9/201611:57SAR Sareum Drug Discovery Co.15,852.00
26/4/201617:292012 Sareum Unleashed4,546.00
20/4/201608:23SAR news is on its way. fasten your seatbelts!172.00

Add a New Thread

Sareum (SAR) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
14:12:410.79197,9621,568.83O
13:55:240.76100,000760.10O
13:28:220.79100,000794.50O
13:12:310.79124,361988.05O
12:34:430.7962,932499.99O
View all Sareum trades in real-time

Sareum (SAR) Top Chat Posts

DateSubject
05/12/2016
08:20
Sareum Daily Update: Sareum Holdings is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker SAR. The last closing price for Sareum was 0.80p.
Sareum Holdings has a 4 week average price of 0.85p and a 12 week average price of 0.94p.
The 1 year high share price is 1.65p while the 1 year low share price is currently 0.19p.
There are currently 2,645,223,988 shares in issue and the average daily traded volume is 11,017,153 shares. The market capitalisation of Sareum Holdings is £20,500,485.91.
01/12/2016
19:18
goose feathers: Price sensitive information. Aurora failure is price sensitive so why was it not given out earlier than the results. The share price really tells a story from great ( slightly undervalued and not the greatest company to do a deal with) first deal for chk 1 - to the usual Sareum everything is next year next august next summer next next next. The whole company with exception of chk1 is " run on the smell of an oily rag"
24/10/2016
07:53
hlp_4u: So now we have three drugs in the melting pot....that appear to work at the T1 level. Tim needs to get on the phone to Roger Daltrey at the Teenage Cancer Trust about TYK....meanwhile the share price continues to tank... methinks someone has a shopping list but is a bit of a spendthrift.....the proceeds from Chk1 should cover the development costs of this but maybe a placing to raise 5 million would be sensible ????? DYOR GLA
27/9/2016
16:11
andrbea: better link Work on the new drug will be expanded into the US. hTTp://www.cambridge-news.co.uk/share-price-leaps-150-for-cambridge-cancer-company/story-29754996-detail/story.html#etzHthoiQSC8VASO.99
27/9/2016
15:51
hastings: hxxp://www.cambridge-news.co.uk/share-price-leaps-150-for-cambridge-cancer-company/story-29754996-detail/story.html
27/9/2016
13:10
hazelst: Could be buys looking at the share price.
28/7/2016
07:11
h2owater: LSE bb:Today 07:49 Price: 0.70Arbitrage 882 postsmy interpretation of today's RNS:based on the below info contained within today's RNS is, that Sareum now has not one, but two known CHK1 inhibitors i.e. CT244747 which, in conjunction with radiotherapy, has the proven ability to effectively target and treat both head and neck cancers i.e. as disclosed by the ICR in 2013. In addition to the above extremely positive info, we also now have the second of our CHK1 compounds i.e. the CHK1 inhibitor CCT245737 which, as we have been informed, has just commenced first-in-human clinical trials targeting multiple cancer cures and as such and quite understandably is, currently subject to confidentiality in the context of information data release.In conclusion and in light of my above interpretation of the info as presented by Sareum, I am personally extremely upbeat with regard to where on the critical pathway of its myriad of compound developments, Sareum is currently positioned.http://www.investegate.co.uk/sareum-holdings-plc--sar-/rns/movement-in-share-price/201607280700104505F/Observation No OpinionReply to postReport post
24/3/2016
12:10
abryer: History repeating itself here again. The share price rises on no news, the company issues Rns not aware of any reason share price is rising and just by coincidence they have secured placing again. 0.2 - dilution coming up
10/3/2016
13:42
duxy786: Share price movement Sareum, the specialist cancer drug discovery and development business, notes the recent movement in its share price and the Board would like to advise the market that, having published its interim results for the period ended 31 December 2015 on 24 February 2016, it is not aware of any undisclosed reason for this rise -------- Someone's gotta know something for the sustained rise last 3 days. What do you reckon LM, BS to keep the share price to a level by the BOD?
10/3/2016
13:03
liquid millionaire: SAR would be mad not to raise funds now duxy after the massive recent share price rise!
10/3/2016
12:57
duxy786: 10/03/2016 12:55pm UK Regulatory (RNS & others) Sareum (LSE:SAR) Intraday Stock Chart Today : Thursday 10 March 2016 Click Here for more Sareum Charts. TIDMSAR RNS Number : 7178R Sareum Holdings PLC 10 March 2016 SAREUM HOLDINGS PLC ("Sareum") Share price movement Sareum, the specialist cancer drug discovery and development business, notes the recent movement in its share price and the Board would like to advise the market that, having published its interim results for the period ended 31 December 2015 on 24 February 2016, it is not aware of any undisclosed reason for this rise. Sareum Holdings plc
Sareum share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:35 V: D:20161205 14:28:33